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  Reactive oxygen species (ROS) are generated in various cells, including vascular smooth muscle and 
endothelial cells, and regulate ion channel functions. KCa3.1 plays an important role in endothelial 
functions. However, the effects of superoxide and hydrogen peroxide radicals on the expression of this 
ion channel in the endothelium remain unclear. In this study, we examined the effects of ROS donors 
on KCa3.1 expression and the K＋ current in primary cultured human umbilical vein endothelial cells 
(HUVECs). The hydrogen peroxide donor, tert-butyl hydroperoxide (TBHP), upregulated KCa3.1 ex-
pression, while the superoxide donors, xanthine/xanthine oxidase mixture (X/XO) and lysopho-
sphatidylcholine (LPC), downregulated its expression, in a concentration-dependent manner. These 
ROS donor effects were prevented by antioxidants or superoxide dismustase. Phosphorylated extra-
cellular signal-regulated kinase (pERK) was upregulated by TBHP and downregulated by X/XO. In 
addition, repressor element-1-silencing transcription factor (REST) was downregulated by TBHP, and 
upregulated by X/XO. Furthermore, KCa3.1 current, which was activated by clamping cells with 1 μM 
Ca2＋ and applying the KCa3.1 activator 1-ethyl-2-benzimidazolinone, was further augmented by TBHP, 
and inhibited by X/XO. These effects were prevented by antioxidants. The results suggest that hydrogen 
peroxide increases KCa3.1 expression by upregulating pERK and downregulating REST, and augments 
the K＋ current. On the other hand, superoxide reduces KCa3.1 expression by downregulating pERK 
and upregulating REST, and inhibits the K＋ current. ROS thereby play a key role in both physiological 
and pathological processes in endothelial cells by regulating KCa3.1 and endothelial function.
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INTRODUCTION
  Vascular endothelial cells are in contact with blood cells 
and vascular smooth muscle cells, and are therefore con-
stantly exposed to reactive oxygen species (ROS) that are 
released from these cell types on activation [1,2]. Moreover, 
endothelial cells themselves generate ROS by stimulation 
with various substances in plasma [1,2]. ROS play a key 
role in the physiological and pathological processes in endo-
thelial cells; hydrogen peroxide upregulates endothelial NO 
synthase (eNOS) [3], and serves as an endothelium-derived 
hyperpolarizing factor (EDHF) that mediates vascular re-
laxation [4,5]. Conversely, superoxide impacts endothelial 
function by downregulating the expression of eNOS [3], 
thus mediating vascular contraction [6,7]. In addition, ex-
cessive ROS production damages endothelial cells, leading 
to endothelial dysfunction [1]. 
  ROS may regulate cellular function by affecting ion 
channels. ROS were shown to regulate various types of ion 
channels, such as Ca2＋-dependent K＋ channels [8,9], ATP- 
sensitive K＋ channel [9,10], HERG channels [11], and Ca2＋ 
channels [12,13], and also affected Ca2＋ release-activated 
Ca2＋ current [14]. In addition, ROS exert complex effects 
on voltage-dependent K＋ channels (Kvs). Hydrogen per-
oxide significantly accelerated the activation kinetics of 
Kv1.4 and Kv3.4, whereas did not alter Kv1.3, Kv2.1 and 
Kv2.2 [15]. In addition, hydrogen peroxide negatively shift-
ed the activation curve of Kv1.5 [16]. Conversely, super-
oxide decreased the strength of the current through this 
channel [17]. Ca2＋-dependent K＋ channels were activated 
by hydrogen peroxide [8] or superoxide [9] radicals, result-
ing in the hyperpolarization of the membrane, or dilation 
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of cerebral arterioles. Both superoxide and hydrogen per-
oxide radicals enhanced the activity of large-conductance 
Ca2＋-dependent K＋ channel in rat and cat cerebral arterio-
les; in contrast, the peroxynitrite radical decreased this ac-
tivity in rat cerebral arteries [18].
  Evidence indicates that KCa3.1 profoundly regulates en-
dothelial function. It mediates a part of the endothe-
lium-derived hyperpolarization response, and contributes to 
endothelium-dependent relaxation of blood vessels. In addi-
tion, KCa3.1 modulates Ca2＋ influx in endothelial cells. On 
inhibition of KCa3.1, Ca2＋ influx and endothelium-depend-
ent relaxation effects were abrogated [19]. Thus, KCa3.1 
dysregulation causes endothelial dysfunction, and thereby 
may contribute to vascular diseases such as preeclampsia 
[20] and Fabry disease [21]. In KCa3.1-deficient mice, the 
endothelial KCa3.1 current was abolished, leading to a con-
siderable increase in arterial blood pressure and to a mild 
left ventricular hypertrophy [22]. We previously reported 
that in α-galactosidase A-knockout mice (an animal model 
of Fabry disease), endothelial dysfunction is caused by 
KCa3.1 downregulation and dysfunction [21]. Furthermore, 
we suggested that KCa3.1 downregulation contributes to the 
endothelial dysfunction seen in preeclampsia [20]. Howev-
er, the role of ROS in the regulation of endothelial KCa3.1 
has received little attention. 
  In the present study, we compared the effects of hydrogen 
peroxide and superoxide radicals on KCa3.1 expression in 
human umbilical vein endothelial cells (HUVECs). We 
found that the hydrogen peroxide radical donor TBHP in-
creased KCa3.1 expression by upregulating pERK expres-
sion and downregulating repressor element-1 silencing 
transcription factor (REST) expression, and augmented 
KCa3.1 current. On the other hand, the superoxide donor, 
xanthine/xanthine oxidase mixture (X/XO), or L-α-lysopho-
sphatidylcholine (LPC) decreased KCa3.1 expression by 
downregulating pERK expression and upregulating REST 
expression, and inhibited KCa3.1 current.
METHODS
Cell culture
  Endothelial cells were isolated from human umbilical 
veins by collagenase treatment, as previously described 
[23]. HUVECs in suspension were plated into 6 well cell 
culture plates and grown in complete M199 (Hyclone, 
Logan, UT) supplemented with 10% fetal bovine serum 
(FBS; Life Technologies Corp., Carlsbad, CA), 100 units/ml 
penicillin, 100 μg/ml streptomycin, 15 μg/ml endothelial 
cell growth supplement (BD Biosciences, Rockville, MD), 
0.1 mM MEM non-essential amino acids (Life Technologies 
Corp., Carlsbad, CA) and 10 unit/ml heparin. Cultured cells 
were identified as endothelial cells in origin by their cobble 
stone appearance at confluence and positive staining with 
1,1’-dioctadecyl-3,3,3’,3’-tetramethyl-indocarbocyanine per-
chlorate-labelled acetylated low density lipoprotein (Biome-
dical Technologies Inc., Stoughton, MA). HUVECs were 
used up to the second or third passage. 
  The investigation was approved by local ethics commit-
tee, the Institutional Review Board of the Ewha Womans 
University, and was in accordance with the Declaration of 
Helsinki.
Real-time PCR and immunoblot analysis
  RNA isolation was performed using the RNeasy Mini Kit 
(Qiagen, Valencia, CA), and RNA was then reverse tran-
scribed using a High Capacity cDNA Archive Kit (Applied 
Biosystems, Foster City, CA). PCRs were performed on an 
ABI 7000 sequence detection system (Applied Biosystems) 
using a SYBR Green PCR Master Mix (Applied Biosys-
tems). Primers for REST were 5'-GTGCGAACTCACACA-
GGAGA-3' (sense) and 5'-AAGAGGTTTAGGCCCGTTGT-3' 
(antisense). mRNA expression was normalized to the 
house-keeping gene, human Gapdh (5-GGCCTCCAAGGA-
GTAAGACC-3' (sense) and 5'-AGGGGTCTACATGGCAA-
CTG-3' (antisense)).
  For immunoblot analysis, 30 μg of protein from cell ho-
mogenates was subjected to sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (7.5∼12% gels), and pro-
teins were then transferred to a nitrocellulose membrane. 
Membranes were blocked for 1 hour with TBST (10 mM 
Tris-HCl, 150 mM NaCl, and 1% Tween 20, pH 7.6) contain-
ing 5% bovine serum albumin at room temperature. The 
blots were incubated for 3 hours with primary antibody 
against primary KCa3.1 antibody (IK1; Santa Cruz Biotech-
nology, Santa Cruz, CA), or p-ERK (Cell Signaling Technol-
ogy, Beverly, MA), followed by incubation with horseradish 
peroxidase-conjugated secondary antibodies for 1 hour. 
Bands were visualized by chemiluminescence. Data collec-
tion and processing were performed using a luminescent 
image analyzer LAS-3000 and Image Gauge software (Fuji- 
Film, Tokyo, Japan).
Immunocytochemistry
  HUVECs were grown on glass coverslips precoated with 
1% gelatin. Cells were incubated overnight at 4oC with a 
diluted (1：50) primary KCa3.1 antibody, washed and in-
cubated for 1 hour at room temperature with a secondary 
antibody, Alexa Flour 488 donkey anti-goat IgG (1：1,500; 
Molecular probes, Eugene, OR). After that, the cells were 
counterstained with 4',6-diamidino-2-phenylindole dihydro-
chloride (DAPI). The mounted coverslips were viewed under 
a confocal microscope (Carl Zeiss, Gottingen, Germany) and 
photographed as described previously [24]. 
Electrophysiology
  The patch-clamp technique was used in whole-cell config-
urations at room temperature. Whole-cell currents were 
measured using ruptured patches and monitored in volt-
age-clamp modes with an EPC-9 (HEKA Elektronik, Lam-
brecht, Germany). The holding potential was 0 mV and cur-
rents were monitored by the repetitive application of volt-
age ramps from －100 to ＋100 mV with a 10-second inter-
val (sampling interval 0.5 milliseconds, 650 millisecond du-
ration). The standard external solution contained (in mM): 
150 NaCl, 6 KCl, 1.5 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, 
pH adjusted to 7.4 with NaOH. The pipette solution for 
whole-cell recording contained (in mM): 40 KCl, 100 K-as-
partate, 2 MgCl2, 0.1 EGTA, 4 Na2ATP, 10 HEPES, pH ad-
justed to 7.2 with KOH. For buffering free Ca2＋, the appro-
priate amount of Ca2＋ (calculated using CaBuf software; 
G. Droogmans, Leuven, Belgium; ftp://ftp.cc.kuleuven.ac.be/ 
pub/droogmans/cabuf.zip) was added in the presence of 5 
mM EGTA. 
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Fig. 1. KCa3.1 expression in ROS donor-treated HUVECs. KCa3.1 
expression was measured using immunoblot, and relative protein 
expression was represented as a ratio of the levels in the vehicle- 
treated group to that in the test group. HUVECs were treated with 
TBHP (A), X/XO (B), or LPC (C), for 24 h; n=4∼7. *p＜0.05, **p＜
0.01 versus vehicle-treated control.
Fig. 2. KCa3.1 expression in ROS donor-treated HUVECs. KCa3.1 
expressions were measured using immunocytochemistry. HUVECs 
were treated with 50 μM TBHP (A), or 50 μM/50 mU/ml X/XO 
(B), for 24 h. Immunocytochemistry images show KCa3.1 staining 
in green, and nuclear staining with DAPI in blue; combined images 
are also presented.
  KCa3.1 current was activated by loading 1 μM Ca2＋ via 
a patch pipette in whole-cell clamped HUVECs and adding 
the KCa3.1 activator 1-ethyl-2-benzimidazolinone (1-EBIO, 
100 μM) to the external solution. KCa3.1 current was nor-
malized to cell capacitance and the selective KCa3.1 blocker 
TRAM-34-sensitive current was measured as KCa3.1 
current.
Chemicals
  LPC from egg yolk, N-acetyl-L-cysteine (NAC), super-
oxide dismutase (SOD), TBHP, tempol, tiron and TRAM-34 
were purchased from Sigma-Aldrich (St. Louis, MO); DAPI 
from Molecular Probes (Eugene, OR), X/XO from 
Calbiochem (Gibbstown, NJ), 1-EBIO from Tocris Biosci-
ence (Ellisville, MO). TRAM-34 and 1-EBIO were applied 
to the bath solution at 10 μM and 100 μM, respectively. 
LPC, NAC, tempol, tiron, TRAM-34 and 1-EBIO were dis-
solved in DMSO. The final concentration of DMSO was less 
than 0.05%.
Statistical analysis
  Pooled data are given as mean±SEM. Statistical evalua-
tion of data was performed by Student t test. Values of p 
＜0.05 were considered significant. 
RESULTS 
Effect of ROS donors on endothelial KCa3.1 expression 
  We examined whether the ROS donors, TBHP or X/XO, 
can modulate KCa3.1 expression in endothelial cells. Pri-
mary HUVECs were incubated with ROS donors or vehicle 
for 24 h, followed by western blot analysis of protein ex-
pression (Fig. 1). Treatment with the hydrogen peroxide do-
nor TBHP, but not the vehicle, unregulated KCa3.1 ex-
pression in a concentration-dependent manner (Fig. 1A). In 
contrast, treatment with the superoxide donor X/XO, but 
not the vehicle, downregulated KCa3.1 expression in a con-
centration-dependent manner (Fig. 1B). In addition, we ex-
amined the effects of LPC, a molecule involved in super-
oxide generation in endothelial cells [3], on KCa3.1 ex-
pression (Fig. 1C). Similar to the X/XO effect, treatment 
with LPC decreased KCa3.1 expression in a concentration- 
dependent manner. To corroborate these findings we next 
examined whether ROS donors affected KCa3.1 expression 
in HUVECs by using immunocytochemical staining to de-
tect expression of KCa3.1 protein (Fig. 2). KCa3.1 expression 
(indicated by green florescence) was markedly increased in 
HUVECs treated with TBHP compared to those treated 
with vehicle (Fig. 2A). In contrast, KCa3.1 expression was 
markedly lower in HUVECs treated with X/XO than in 
those treated with vehicle (Fig. 2B). These results, which 
indicate that KCa3.1 expression is upregulated or down-
regulated following treatment with TBHP and X/XO, re-
spectively, suggest that the hydrogen peroxide and super-
oxide radicals exert converse effects on the expression of 
this ion channel.
Antioxidants prevent ROS donor-induced modulation 
of KCa3.1 expression
  We then examined whether treatment with antioxidants 
or SOD could prevent the ROS donor- or LPC-induced mod-
ulation of KCa3.1 expression. Pre-treatment of HUVECs 
with the antioxidants tempol, tiron, or NAC prevented 
TBHP-induced upregulation (Fig. 3A), as well as X/XO-in-
duced downregulation (Fig. 3B) of KCa3.1 expression. Fur-
thermore, LPC-induced KCa3.1 downregulation was abro-
gated by pre-treatment with SOD (Fig. 3B). In combination, 
these findings reinforce that KCa3.1 is upregulated by the 
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Fig. 3. Effects of antioxidants on ROS donor-induced KCa3.1 
regulation. HUVECs were treated with vehicle or 100 μM TBHP 
(A), 100 μM/100 mU/ml X/XO (B), or 100 μM LPC (C), for 24 h, 
with or without pre-treatment with antioxidants (5 μM tempol, 
50 μM tiron, or 10 mM NAC), or SOD (1,000 U/ml). The results 
are mean±SEM of three independent experiments. **p＜0.01 
versus TBHP, X/XO or LPC alone.
Fig. 5. Effect of ROS donors on REST expression in HUVECs. REST 
expression was measured using real-time PCR and the relative 
expression of mRNA was expressed as a ratio of the levels in the 
vehicle-treated group to that in the test group. HUVECs were 
treated with TBHP (A) or X/XO (B) for 24 h; n=4∼7. *p＜0.05, **p
＜0.01 versus control.
Fig. 4. Effect of ROS donors on pERK expression in HUVECs. pERK 
expression was measured using immunoblot, and relative protein 
expression was expressed as a ratio of the levels in the vehicle- 
treated group to that in the test group. HUVECs were treated with 
TBHP (A), X/XO (B), or LPC (C), for 24 h; n=4∼7. *p＜0.05, **p
＜0.01, ***p＜0.005 versus vehicle-treated control.
Fig. 6. Effect of ROS donors on KCa3.1 current in HUVECs. KCa3.1 
current was activated by loading cells with 1 μM Ca2＋ by using 
a patch pipette, and treating the cells with 1-EBIO (100 μM). The 
KCa3.1 currents were normalized to cell capacitance, and the 
TRAM-34-sensitive current was measured as the KCa3.1 current. 
(A, B, D, F) Current densities are shown at a membrane potential 
of ＋50 mV, and marked by open circles, while I/V relationships 
were obtained at the points marked by closed circles. (C, F) KCa3.1 
current densities at ＋50 mV; n=6∼8 (right panel). *p＜0.05 versus 
control.
hydrogen peroxide radical, and downregulated by the su-
peroxide radical.
Effect of ROS donors on pERK and REST 
  To further evaluate the molecular mechanisms of ROS 
donor-induced modulation of KCa3.1 expression, we exam-
ined whether ROS donors affected the signal transduction 
pathways involved in KCa3.1 expression, the ERK pathway 
[25] and REST [26]. We thus assessed the phosphorylation 
of ERK (pERK) by immunoblot analysis (Fig. 4). TBHP 
treatment for 24 h significantly increased the levels of 
pERK in HUVECs (34±4% and 145±30% increase by 25 and 
100 μM TBHP, respectively; Fig. 4A). In contrast, pERK 
levels were significantly reduced in HUVECs treated with 
X/XO (25 μM/25 mU/ml) for 24 h (57±4% inhibition; Fig. 
4B). In addition, LPC reduced the level of pERK in a con-
centration-dependent manner in HUVECs (Fig. 4C). We 
then examined whether ROS donors modulate KCa3.1 ex-
pression by regulating the REST pathway. The expression 
of this transcription factor in HUVECs was significantly 
downregulated after incubation with TBHP in a concen-
tration-dependent manner (29±3% decrease by 25 μM 
TBHP; Fig. 5A). In contrast, X/XO significantly upregulated 
REST expression in HUVECs (83±16% increase by 100 μM/ 
100 mU/ml X/XO; Fig. 5B). These data suggest that TBHP 
upregulates KCa3.1 by activating the ERK pathway and 
downregulating REST. Conversely, X/XO downregulates 
KCa3.1 by inhibiting the ERK pathway and increasing 
REST expression.
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ROS donors modulate KCa3.1 currents in endothelial 
cells 
  We next examined whether the ROS donors could modu-
late KCa3.1 current, which was activated by loading whole 
cell-clamped HUVECs with 1 μM Ca2＋, via a patch pipette, 
and supplementing the medium with the KCa3.1 activator 
1-EBIO (100 μM). When the KCa3.1 current reached a 
steady state, TBHP or X/XO was applied in the external 
solution. The activated KCa3.1 current was further en-
hanced by TBHP (Fig. 6A, C), but it was inhibited by X/XO 
(Fig. 6D, F). The effect of TBHP (Fig. 6B, C), or X/XO (Fig. 
6E, F) was inhibited by tempol. These data suggest that 
KCa3.1 current is augmented by the hydrogen peroxide radi-
cal, and inhibited by the superoxide radical.
DISCUSSION 
  In this study, we show that ROS regulate KCa3.1 ex-
pression through the modulation of the ERK and REST 
pathways, and influence KCa3.1 current production in hu-
man endothelial cells. The hydrogen peroxide donor TBHP 
increases KCa3.1 expression through pERK upregulation 
and REST downregulation. In contrast, the superoxide do-
nors X/XO and LPC decrease KCa3.1 expression through 
pERK downregulation and REST upregulation. In addition, 
KCa3.1 current is augmented by TBHP, and inhibited by 
X/XO. These findings shed light on the mechanisms under-
lying ROS-mediated regulation of this ion channel, a proc-
ess that may be implicated in ROS-induced modulation of 
endothelial function. 
  Furthermore, the effects of the ROS donors, TBHP, XXO, 
or LPC were nullified by pre-treatment with antioxidants. 
The upregulation in KCa3.1 expression by the hydrogen per-
oxide donor TBHP was abrogated by antioxidants, suggest-
ing that this effect is mediated by the hydrogen peroxide 
radical. In parallel, antioxidant treatment also nullified the 
ion-channel downregulating effects of the superoxide radi-
cal donors X/XO or LPC. LPC suppressed SOD1 and in-
creased catalase expression [3], indicating that LPC in-
creases the production of the superoxide, but not the hydro-
gen peroxide radical. These results suggest that X/XO- or 
LPC-induced downregulation of KCa3.1 is mediated by the 
superoxide radical. Since the ion channel KCa3.1 is an im-
portant physiological modulator in the endothelium, these 
findings suggest that ROS may affect endothelial function 
by regulating KCa3.1 expression and function. 
  Superoxide and hydrogen peroxide radicals are generated 
in vascular endothelial cells by several cellular enzymes, 
including eNOS, cytochrome P-450, and NADPH oxidases 
[27]. eNOS was suggested to contribute to ROS production 
in the endothelium, since acetylcholine-induced hydrogen 
peroxide radical production was markedly reduced in the 
blood vessels of eNOS-knockout mice [5], and eNOS activa-
tion generates superoxide radicals under the depletion of 
tetrahydrobiopterin [28,29]. In addition, cytochrome P-450 
may be a source of ROS, since the hydrogen peroxide radi-
cal was produced in a cytochrome P-450-dependent manner 
in the coronary arteries of rats [30] and pigs [31]. NADPH 
oxidases play an important role in the generation of endo-
thelial superoxide radicals. The enzymes are regulated by 
various stimuli such as shear stress, hypoxia, and hyper-
lipidemia [2]. Since the production of superoxide radicals 
promotes generation of hydrogen peroxide radicals through 
SOD, both free radicals may be produced in endothelial 
cells in response to various stimuli, and may thereby regu-
late KCa3.1 expression and its function.
  KCa3.1 expression is upregulated by the ERK pathway 
[25] and downregulated by REST [26]. External stress and 
physiological stimuli can affect the MAPK pathway by gen-
erating ROS [32]. Blood flow regulates KCa3.1 expression; 
a laminar flow upregulates KCa3.1 by increasing hydrogen 
peroxide generation, whereas turbulent flow downregulates 
KCa3.1 by increasing superoxide generation [33,34]. ERK 
phosphorylation and eNOS expression were inhibited by su-
peroxide donors, but stimulated by the hydrogen peroxide 
radical donor THBP [3]. Thus, an inhibition of ERK phos-
phorylation may suppress KCa3.1 expression, as suggested 
previously [25]. In addition, ROS can activate as well as 
inactivate transcription factors [35]. The apparent regu-
lation of REST levels and activity by transcriptional and 
post-transcriptional mechanisms [36] suggest that ROS are 
likely to regulate REST by affecting transcription factors. 
In addition, REST can modulate the phosphoinositide-3 
kinase-Akt/ERK pathway, since cells lacking REST exhibit 
increased phosphoinositide-3 kinase signalling [37].
  There are many reports on the superoxide or hydrogen 
peroxide radical-induced modulation of K＋ currents, such 
as KCa1.1 current [38-40], the voltage-dependent K＋ current 
[16,17], and the ATP-sensitive K＋ current [10,38]. Howev-
er, this is the first report of the superoxide or hydrogen 
peroxide radical-induced modulation of the current gen-
erated through the ion channel KCa3.1. We observed that 
the hydrogen peroxide radical stimulates KCa3.1 current in 
cells dialyzed with 5 mM EGTA. It is possible that a hydro-
gen peroxide radical-induced increase in cytosolic free Ca2＋ 
[41,42] could lead to activation of KCa current. However, 
a high intracellular EGTA concentration may buffer the in-
crease in Ca2＋ induced by ROS. Since KCa3.1 current is acti-
vated in a voltage- and cytosolic free Ca2＋-dependent man-
ner, the augmentation of KCa3.1 current by the hydrogen 
peroxide radical suggests that this radical increases the 
sensitivity of KCa3.1 channel to voltage, or cytosolic free Ca2＋.
  In conclusion, the ROS donors TBHP, X/XO, and LPC 
regulate KCa3.1 expression in HUVECs. In addition, KCa3.1 
current is modulated by the ROS donors TBHP, and X/XO. 
These ROS donor effects on KCa3.1 expression and the K＋ 
current are prevented by pre-treatment with antioxidants. 
KCa3.1 plays an important role in vasomotor regulation; 
therefore, modulation of this ion channel in the vascular 
endothelium may be useful in the treatment of athero-
sclerosis and endothelial damage.
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